{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:32:29Z","timestamp":1774344749817,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH081014"],"award-info":[{"award-number":["R01MH081014"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH102951"],"award-info":[{"award-number":["R01MH102951"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K23MH106683"],"award-info":[{"award-number":["K23MH106683"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.schres.2018.12.028","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T21:07:56Z","timestamp":1546981676000},"page":"239-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia"],"prefix":"10.1016","volume":"210","author":[{"given":"Nina V.","family":"Kraguljac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charity J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith A.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ripu D.","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumya","family":"Sivaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridgette K.","family":"Martinak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne C.","family":"Lahti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.schres.2018.12.028_bb0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0006-3223(00)00997-5","article-title":"The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia","volume":"49","author":"Bertolino","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2018.12.028_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-014-3649-4","article-title":"Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia","volume":"232","author":"Bishop","year":"2015","journal-title":"Psychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.schres.2018.12.028_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0920-9964(02)00210-4","article-title":"Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure","volume":"58","author":"Bustillo","year":"2002","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.schres.2018.12.028_bb0020","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1038\/sj.npp.1301631","article-title":"Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia","volume":"33","author":"Bustillo","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.schres.2018.12.028_bb0025","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/npp.2015.72","article-title":"The paradoxical relationship between white matter, psychopathology and cognition in schizophrenia: a diffusion tensor and proton spectroscopic imaging study","volume":"40","author":"Caprihan","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.schres.2018.12.028_bb0030","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archpsyc.57.6.533","article-title":"Decisional capacity for informed consent in schizophrenia research","volume":"57","author":"Carpenter","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2018.12.028_bb0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1566524015666150303104811","article-title":"Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia","volume":"15","author":"Coughlin","year":"2015","journal-title":"Curr. Mol. Med."},{"issue":"10","key":"10.1016\/j.schres.2018.12.028_bb0040","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamapsychiatry.2013.289","article-title":"Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study","volume":"70","author":"de la Fuente-Sandoval","year":"2013","journal-title":"JAMA Psychiat."},{"issue":"5","key":"10.1016\/j.schres.2018.12.028_bb0045","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1124\/mol.108.046540","article-title":"Messing up with traffic: different effects of antipsychotic agents on glutamate receptor complexes in vivo","volume":"73","author":"Del'guidice","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.schres.2018.12.028_bb0050","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fpsyt.2017.00066","article-title":"Effects of antipsychotic administration on brain glutamate in schizophrenia: a systematic review of longitudinal 1H-MRS studies","volume":"8","author":"Egerton","year":"2017","journal-title":"Front. Psych."},{"issue":"11","key":"10.1016\/j.schres.2018.12.028_bb0055","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/s41380-018-0082-9","article-title":"Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre (1)H-MRS study (OPTiMiSE)","volume":"23","author":"Egerton","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2018.12.028_bb0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/schbul\/sbv124","article-title":"Cross-sectional study of glutamate in the anterior cingulate and hippocampus in schizophrenia","volume":"42","author":"Gallinat","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2018.12.028_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pscychresns.2014.04.010","article-title":"Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: a magnetic resonance spectroscopy study","volume":"223","author":"Gan","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2018.12.028_bb0070","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2147\/NDT.S61415","article-title":"The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naive first-episode patients with schizophrenia: a preliminary study","volume":"10","author":"Grosic","year":"2014","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.schres.2018.12.028_bb0075","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1023\/A:1023231611616","article-title":"Alterations in NMDA receptor subunit levels in the brain regions of rats chronically administered typical or atypical antipsychotic drugs","volume":"28","author":"Hanaoka","year":"2003","journal-title":"Neurochem. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2018.12.028_bb0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2014.09.041","article-title":"GABAergic mechanisms of hippocampal hyperactivity in schizophrenia","volume":"167","author":"Heckers","year":"2015","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2018.12.028_bb0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.schres.2012.06.039","article-title":"Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging","volume":"140","author":"Hutcheson","year":"2012","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2018.12.028_bb0090","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hbm.22714","article-title":"Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication","volume":"36","author":"Hutcheson","year":"2015","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.schres.2018.12.028_bb0095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pnpbp.2018.03.016","article-title":"Neurometabolite levels in antipsychotic-naive\/free patients with schizophrenia: a systematic review and meta-analysis of (1)H-MRS studies","volume":"86","author":"Iwata","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2018.12.028_bb0100","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/schbul\/sbs100","article-title":"Twenty-five years of glutamate in schizophrenia: are we there yet?","volume":"38","author":"Javitt","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.schres.2018.12.028_bb0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archgenpsychiatry.2011.1519","article-title":"Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy","volume":"69","author":"Kegeles","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2018.12.028_bb0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0006-3223(00)00940-9","article-title":"Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings\u2013part II","volume":"48","author":"Keshavan","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2018.12.028_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pscychresns.2012.02.003","article-title":"Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis","volume":"203","author":"Kraguljac","year":"2012","journal-title":"Psychiatry Res."},{"issue":"12","key":"10.1016\/j.schres.2018.12.028_bb0120","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1038\/npp.2012.126","article-title":"Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia","volume":"37","author":"Kraguljac","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.schres.2018.12.028_bb0125","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jamapsychiatry.2013.2437","article-title":"Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia","volume":"70","author":"Kraguljac","year":"2013","journal-title":"JAMA Psychiat."},{"issue":"12","key":"10.1016\/j.schres.2018.12.028_bb0130","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hipo.22332","article-title":"Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia","volume":"24","author":"Kraguljac","year":"2014","journal-title":"Hippocampus"},{"issue":"4","key":"10.1016\/j.schres.2018.12.028_bb0135","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/schbul\/sbv228","article-title":"Aberrant hippocampal connectivity in unmedicated patients with schizophrenia and effects of antipsychotic medication: a longitudinal resting state functional MRI study","volume":"42","author":"Kraguljac","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2018.12.028_bb0140","first-page":"231","article-title":"Mnemonic discrimination deficits in first-episode psychosis and a ketamine model suggests dentate gyrus pathology linked to N-methyl-d-aspartate receptor hypofunction","volume":"3","author":"Kraguljac","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2018.12.028_bb0145","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/mp.2016.122","article-title":"Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers","volume":"22","author":"Kraguljac","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2018.12.028_bb0150","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.pharep.2015.01.017","article-title":"Effects of long-term treatment with the neuroleptics haloperidol, clozapine and olanzapine on immunoexpression of NMDA receptor subunits NR1, NR2A and NR2B in the rat hippocampus","volume":"67","author":"Krzystanek","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.schres.2018.12.028_bb0155","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00001756-199504190-00011","article-title":"Ketamine activates psychosis and alters limbic blood flow in schizophrenia","volume":"6","author":"Lahti","year":"1995","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.schres.2018.12.028_bb0160","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.schres.2018.12.028_bb0165","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.schres.2018.12.028_bb0170","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0006-3223(02)01602-5","article-title":"Functional effects of antipsychotic drugs: comparing clozapine with haloperidol","volume":"53","author":"Lahti","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2018.12.028_bb0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.npp.1300837","article-title":"Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia","volume":"31","author":"Lahti","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2018.12.028_bb0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/schbul\/sbr069","article-title":"Glutamate in schizophrenia: a focused review and meta-analysis of (1)H-MRS studies","volume":"39","author":"Marsman","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.schres.2018.12.028_bb0185","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamapsychiatry.2016.0442","article-title":"Nature of glutamate alterations in schizophrenia: a meta-analysis of proton magnetic resonance spectroscopy studies","volume":"73","author":"Merritt","year":"2016","journal-title":"JAMA Psychiat."},{"issue":"11","key":"10.1016\/j.schres.2018.12.028_bb0190","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.4088\/JCP.v68n1115","article-title":"The Texas medication algorithm project antipsychotic algorithm for schizophrenia: 2006 update","volume":"68","author":"Moore","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2018.12.028_bb0195","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archpsyc.1994.03950110009002","article-title":"Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH genetics initiative","volume":"51","author":"Nurnberger","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2018.12.028_bb0200","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2018.12.028_bb0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pscychresns.2008.06.002","article-title":"Creatine abnormalities in schizophrenia and bipolar disorder","volume":"172","author":"Ongur","year":"2009","journal-title":"Psychiatry Res."},{"issue":"2\u20133","key":"10.1016\/j.schres.2018.12.028_bb0210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.schres.2013.12.013","article-title":"Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings","volume":"152","author":"Poels","year":"2014","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2018.12.028_bb0215","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.biopsych.2010.04.013","article-title":"Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia","volume":"68","author":"Reid","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2018.12.028_bb0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1176\/appi.ajp.2014.13101355","article-title":"Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study","volume":"172","author":"Robinson","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2018.12.028_bb0225","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.neuroimage.2003.11.014","article-title":"Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 tesla","volume":"21","author":"Schubert","year":"2004","journal-title":"NeuroImage"},{"key":"10.1016\/j.schres.2018.12.028_bb0230","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1038\/tp.2016.10","article-title":"Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes","volume":"6","author":"Stevenson","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2018.12.028_bb0235","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0031-1279739","article-title":"Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment","volume":"44","author":"Szulc","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.schres.2018.12.028_bb0240","first-page":"6","article-title":"Neurometabolic abnormalities in schizophrenia and depression observed with magnetic resonance spectroscopy at 7\u202fT","volume":"3","author":"Taylor","year":"2017","journal-title":"BJ Psych. Open"},{"issue":"1","key":"10.1016\/j.schres.2018.12.028_bb0245","first-page":"112","article-title":"Anchoring the BPRS: an aid to improved reliability","volume":"24","author":"Woerner","year":"1988","journal-title":"Psychopharmacol. Bull."},{"issue":"9","key":"10.1016\/j.schres.2018.12.028_bb0250","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archpsyc.63.9.969","article-title":"Prediction of functional outcome 18\u202fmonths after a first psychotic episode: a proton magnetic resonance spectroscopy study","volume":"63","author":"Wood","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418307242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418307242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T23:40:53Z","timestamp":1565221253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418307242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":50,"alternative-id":["S0920996418307242"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.12.028","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}